Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DD08	MAGNACEF	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	349,399 L.L
J01DD08	MAGNACEF	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	700,142 L.L
J01DD08	MUREX	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	524,099 L.L
R05CB03	MUCOTAL PEDIATRIQUE	G	Carbocysteine - 100mg/5ml	100mg/5ml	Syrup	298,205 L.L
B05XA05	MAGNESIUM SULFATE	G	Magnesium sulfate, 7H2O - 10g/100ml	10g/100ml	Injectable solution	5,040,303 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	329,815 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	494,147 L.L
N02AA01	MST CONTINUS	B	Morphine sulfate - 10mg	10mg	Tablet, film coated, prolonged release	972,942 L.L
N06AB10	MEDIPREX	G	Escitalopram - 10mg	10mg	Tablet, film coated	456,906 L.L
L01BB04	MAVENCLAD	B	Cladribine - 10mg	10mg	Tablet	200,244,812 L.L
A03FA01	METOCLOPRAMIDE	G	Metoclopramide HCl - 10mg	10mg	Tablet	172,012 L.L
A03FA03	MOTILIUM	B	Domperidone - 10mg	10mg	Tablet	353,431 L.L
A03FA03	MODODOM	G	Domperidone - 10mg	10mg	Tablet, film coated	147,823 L.L
A03FA03	MOTILAT	G	Domperidone - 10mg	10mg	Tablet	221,734 L.L
L01BB04	MAVENCLAD	B	Cladribine - 10mg	10mg	Tablet	L.L
A03FA03	MOTIDOL ODT	G	Domperidone - 10mg	10mg	Tablet, orodispersible	259,810 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	978,317 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	1,136,296 L.L
R03DC03	MOTRINEX	G	Montelukast - 10mg	10mg	Tablet, film coated	802,274 L.L
N06DX01	MEMANTINE ARROW LAB	G	Memantine HCl - 10mg	10mg	Tablet, film coated, scored	1,404,315 L.L
N06DX01	MEMANTINE BIOGARAN	G	Memantine HCl - 10mg	10mg	Tablet, coated, scored	2,444,450 L.L
N06DX01	MEMORA	G	Memantine HCl - 10mg	10mg	Tablet, film coated	849,820 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 10mg/0.2ml	10mg/0.2ml	Injectable solution	1,553,482 L.L
A03FA01	METOCLOPRAMIDE S.A.L.F.	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	255,330 L.L
A03FA01	METORAM	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	421,071 L.L
A03FA01	METORAM	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	3,026,845 L.L
N02AA01	MORPHILINE	G	Morphine sulfate - 10mg/5ml	10mg/5ml	Solution	189,418 L.L
A10BX16	MOUNJARO KWIKPEN	B	Tirzepatide - 10mg/dose	10mg/dose	Injectable solution	39,601,065 L.L
N02AA01	MORPHINE MEDIS	G	Morphine HCl - 10mg/ml	10mg/ml	Injectable solution	1,050,885 L.L
D10AF01	MEDACIN T	G	Clindamycin (phosphate) - 10mg/ml	10mg/ml	Solution	314,459 L.L

...